位置:成果数据库 > 期刊 > 期刊详情页
口咽鳞癌组织中HPV16感染和p16蛋白表达的临床意义
  • ISSN号:1672-4992
  • 期刊名称:现代肿瘤医学
  • 时间:2015.5
  • 页码:1813-1818
  • 分类:R739.63[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]中南大学湘雅医院耳鼻咽喉头颈外科,湖南长沙410008, [2]耳鼻咽喉重大疾病湖南省重点实验室,湖南长沙410008, [3]中南大学湘雅附二医院病理科,湖南长沙410011, [4]中南大学湘雅医学院,湖南长沙410013
  • 相关基金:国家自然科学基金(编号:81272974,81201740,81372906,81270371)
  • 相关项目:HPV16调控HPV相关口咽癌病人放疗敏感性的分子机制研究
中文摘要:

目的:检测口咽鳞癌中HPV16感染及P16表达率,并分析临床意义。方法:采用原位杂交法检测60例口咽鳞癌组织中HPV16的表达,免疫组化法检测95例口咽鳞癌组织P16的表达情况,分析HPV16与P16的相关性,总结上述两种蛋白在口咽癌中的临床意义。结果:口咽鳞癌组织中HPV16感染率为48.3%(29/60),P16阳性表达率为52.6%(50/95),60例标本中HPV16感染与 P16表达显著相关(P<0.001),用P16表达预测HPV16感染的正确率可达90%(54/60),跟国内外报道一致。P16阳性组相比P16阴性组,吸烟、饮酒、非嚼槟榔、T3+T4、有淋巴结转移、III-IV临床分期和高分化者所占比例更低,但不具有统计学差异( P>0.05)。平均随访时间38个月,随访率65.3%(62/95),62例口咽鳞癌病人中P16阳性组和P16阴性组的3年总体生存率和无瘤生存率分别为70.4%对比40.0%(P=0.008)和63.0%对比25.7%(P=0.004)。总体生存率多因素分析提示,P16阴性病人死亡风险是 P16阳性病人的2.12倍(HR 0.471,95%CI 0.201-1.103,P=0.083),无瘤生存率多因素分析提示,P16阴性病人死亡风险是 P16阳性病人的2.36倍(HR 0.432,95%CI 0.201-0.891,P=0.024),P16与口咽癌的预后密切相关。结论:P16表达和HPV16表达存在紧密相关性,P16可以替代HPV16来预测预后,P16蛋白阳性口咽癌患者具有非吸烟、非饮酒、嚼槟榔和肿瘤分化程度低的趋势,检测P16表达对口咽癌病人预后判断有重要的提示意义。

英文摘要:

Objective:To investigate the infection rate of human PaPillomavirus16( HPV16 )and P16 Protein ex-Pression in oroPharyngeal squamous cell carcinoma( OPSCC)and their clinical significance. Methods:HPV16 DNA was measured by in situ hybridization in 60 sPecimens of OPSCC. P16 Protein was evaluated by immunohistochemistry in 95 sPecimens. We assessed mutual correlation of the HPV16 and P16,and summarized their clinical significance in oroPharyngeal cancer . Results:The incidence rate of HPV infection was 48. 3%(29/60). P16 was exPressed in 52. 6%(50/95)of the tumor tissues. The P16 Protein exPression was highly correlated with the Presence of HPV16 in 60 sPecimens(P0. 05). The mean follow-uP time was 38 months and the follow-uP rate was 65. 3%(62/95). Both OS and DFS were increased in P16 Positive grouP(70. 4% and 63. 0%)comPared with the P16 negative grouP (40. 0% and 25. 7%,P=0. 008 and 0. 004,resPectively)in 62 Patients. When multivariable analysis was Performed in DFS,Patients with P16 Protein negative tumors had a higher risk of death than Patients with P16 Protein Positive tumors(HR 0. 423,95%CI 0. 201 -0. 891,P=0. 024). P16 was closely related to the Prognosis of oroPharyngeal cancer. Conclusion:The P16 Protein exPression was highly correlated with the Presence of HPV16,and might be a surrogate marker for HPV16 to Predict the Prognosis. There was a trend that P16 Protein Positive oroPharyngeal cancer Patients might be non-smokers,non-drinkers,chewing betelers and low degree of tumor differentiation. Detecting the P16 Protein exPression has imPortant Prognostic significance for OPSCC Patients.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《现代肿瘤医学》
  • 中国科技核心期刊
  • 主管单位:陕西省科学技术协会
  • 主办单位:中国抗癌协会 陕西省抗癌协会 陕西省肿瘤防治研究所 (西安交通大学附属陕西省肿瘤医院)
  • 主编:李树业
  • 地址:西安市雁塔西路309号陕西省肿瘤医院内
  • 邮编:710061
  • 邮箱:sxzlyx@263.net
  • 电话:029-85277356
  • 国际标准刊号:ISSN:1672-4992
  • 国内统一刊号:ISSN:61-1415/R
  • 邮发代号:52-297
  • 获奖情况:
  • 获《CAJ-CD规范》执行优秀期刊奖,陕西省优秀科技期刊一等奖,中国抗癌协会优秀期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),中国中国科技核心期刊
  • 被引量:30005